Dermatology & Plastic Surgery Institute Outcomes
Surgical Quality Improvement
Dermatology & Plastic Surgery Institute Outcomes
Dermatology & Plastic Surgery Institute Surgery ACS NSQIP Outcomes
January 1, 2021 – December 31, 2021
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s Dermatology & Plastic Surgery Institute surgery ACS NSQIP performance benchmarked against 457 participating sites.
| Dermatology & Plastic Surgery (457 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 347 | 4.90% | 5.44% |
| Cardiac | 347 | 0.29% | 0.03% |
| Pneumonia | 347 | 0.00% | 0.09% |
| Unplanned Intubation | 347 | 0.00% | 0.01% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 347 | 0.58% | 0.38% |
| Urinary Tract Infection (UTI) | 347 | 0.00% | 0.19% |
| Surgical Site Infection (SSI) | 346 | 4.91% | 4.31% |
| Sepsis | 347 | 0.86% | 0.38% |
| Return to Operating Room (ROR) | 347 | 4.90% | 5.07% |
| Readmission | 347 | 3.46% | 2.99% |
American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.
